Search

Search Constraints

You searched for: Author/Creator Ueda, Kosuke

Search Results

1. Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab. (5th October 2021)

3. Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg. Issue 3 (8th February 2023)

5. Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma. Issue 5 (June 2021)

6. External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort. (22nd January 2021)

7. Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. (1st January 2016)

8. Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. (1st January 2016)

9. Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab. (10th February 2022)